← feed

Is NCT02991261 results overdue?

Yes — results are overdue. Primary completion was 2017-03-15; the FDAAA-801 reporting deadline (2018-03-15) passed 3020 days ago and no results are posted on ClinicalTrials.gov.

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

NCT IDNCT02991261 ↗
SponsorSun Pharma Advanced Research Company Limited (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-03-15 (ACTUAL)
Reporting deadline2018-03-15 (completion + 365d)
Days overdue3020
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 504671f215f1adfd… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02991261. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →